Non-invasive growth factor gene therapy to promote remyelination in multiple sclerosis
Novel AAV-based gene therapy delivering CNS-wide growth factors to promote remyelination and functional recovery in multiple sclerosis, leveraging targets identified from MS patient brain tissue with spontaneous remyelin...